These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Can ofloxacin constitute an alternative antitubercular treatment for BCG hepatitis?]. Fendler JP; Debois H; Mége JL; Kepenekian G Prog Urol; 2002 Apr; 12(2):309-12. PubMed ID: 12108350 [TBL] [Abstract][Full Text] [Related]
28. Fluoroquinolones and tuberculosis. Yew WW; Chau CH Int J Tuberc Lung Dis; 1998 Dec; 2(12):1050-2. PubMed ID: 9869128 [No Abstract] [Full Text] [Related]
29. [Analysis of causes of drug resistance and therapeutic effects on 27 multi-drug resistant pulmonary tuberculosis patients]. Ye Z; Pei X; Yang Y Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):234-6. PubMed ID: 10072811 [TBL] [Abstract][Full Text] [Related]
30. Ofloxacin in multidrug resistant tuberculosis. Walwaikar PP; Morye VK; Gawde AS J Indian Med Assoc; 2003 Mar; 101(3):210-2. PubMed ID: 14603981 [TBL] [Abstract][Full Text] [Related]
31. The treatment of multidrug-resistant tuberculosis in Turkey. Tahaoğlu K; Törün T; Sevim T; Ataç G; Kir A; Karasulu L; Ozmen I; Kapakli N N Engl J Med; 2001 Jul; 345(3):170-4. PubMed ID: 11463011 [TBL] [Abstract][Full Text] [Related]
32. Drug concentration in lung tissue in multidrug-resistant tuberculosis. Akkerman OW; van Altena R; Klinkenberg T; Brouwers AH; Bongaerts AH; van der Werf TS; Alffenaar JW Eur Respir J; 2013 Dec; 42(6):1750-2. PubMed ID: 24293422 [No Abstract] [Full Text] [Related]
33. Chemotherapy for tuberculosis. American Thoracic Society. Singh V Indian Pediatr; 1995 Aug; 32(8):943-4. PubMed ID: 8635851 [No Abstract] [Full Text] [Related]
34. Drug resistant tuberculosis. Singh M; Jayanthi S; Kumar L Indian J Pediatr; 2000 Feb; 67(2 Suppl):S41-6. PubMed ID: 11129907 [TBL] [Abstract][Full Text] [Related]
35. Suboptimal moxifloxacin and levofloxacin drug exposure during treatment of patients with multidrug-resistant tuberculosis: results from a prospective study in China. Davies Forsman L; Niward K; Kuhlin J; Zheng X; Zheng R; Ke R; Hong C; Werngren J; Paues J; Simonsson USH; Eliasson E; Hoffner S; Xu B; Alffenaar JW; Schön T; Hu Y; Bruchfeld J Eur Respir J; 2021 Mar; 57(3):. PubMed ID: 33154028 [No Abstract] [Full Text] [Related]
36. Long-term treatment of pulmonary tuberculosis with ofloxacin in a subject with liver cirrhosis. Bagnato GF; Di Cesare E; Gulli S; Cucinotta D Monaldi Arch Chest Dis; 1995 Aug; 50(4):279-81. PubMed ID: 7550207 [TBL] [Abstract][Full Text] [Related]
37. [Levofloxacin (Tavanic) in the treatment of corneal ulcers]. Maĭchuk IuF Antibiot Khimioter; 2003; 48(6):16-9. PubMed ID: 14558414 [TBL] [Abstract][Full Text] [Related]
38. [Maxaquin in the combined treatment of tuberculosis]. Sokolova GB; Mozhokina GN; Kunichan AD; Elistratova NA; Perel'man MI Probl Tuberk; 2000; (5):35-9. PubMed ID: 11077850 [TBL] [Abstract][Full Text] [Related]
39. [Effectiveness of maxaquin and tarivid in combined therapy of patients with chronic sinusitis]. El'kun GB Vestn Otorinolaringol; 1999; (6):45-6. PubMed ID: 10596605 [No Abstract] [Full Text] [Related]
40. Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines. Grimaldo ER; Tupasi TE; Rivera AB; Quelapio MI; Cardaño RC; Derilo JO; Belen VA Int J Tuberc Lung Dis; 2001 Jun; 5(6):546-50. PubMed ID: 11409582 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]